Worth reading
51Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1800000
Shares (maximum)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock options (share acquisition rights) (Series 10 share acquisition rights)
Who receives how much1,800,000Shares
1,800,000 shares of the Company's common stock (maximum)
4 of the Company’s directors3,040 rights
24 employees of the Company8,000 rights
2 directors of subsidiaries of the Company650 rights
103 employees of the Company's subsidiaries6,110 rights
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
No cash payment is required in exchange for the share acquisition rights.
Terms of the stock acquisition rights
Exercise price
Average closing price for each day of the month preceding the month in which the allotment date falls × 1.1 (rounded up to the nearest yen). However, the exercise price will not be lower than the closing price on the allotment date or the immediately preceding trading day.
Exercise period
Start Date 10 July 2028 / End date 10 July 2036
Number of Stock Acquisition Rights
Total number issued 18,000 rights / Unexercised balance Not disclosed
Reason for acquisition without consideration
If a holder of the share acquisition rights ceases to satisfy the exercise conditions, If approval of a corporate reorganization transaction is approved at a shareholders meeting
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Conditions for lifting transfer restrictions
The share acquisition rights may not be transferred, except with the special approval of the Company's Board of Directors.
Categories and Number of Persons Covered
4 directors of the Company: 3,040 rights, 24 employees of the Company: 8,000 rights, 2 directors of the Company's subsidiaries: 650 rights, 103 employees of the Company's subsidiaries: 6,110 rights
Intended allottee's holding policy
The share acquisition rights may not be transferred, except with the special approval of the Company's Board of Directors.
Basis for determining the amount to be paid
The exercise price will be based on the average closing price of the Company's common stock on the Tokyo Stock Exchange for each trading day in the month preceding the month in which the allotment date falls, multiplied by 1.1 and rounded up to the nearest yen. If this amount is below the closing price on the allotment date, or the closing price on the immediately preceding trading day if no trades are made on the allotment date, the applicable closing price will be used. The discount or premium rate has not been specified.
Procedures under the Corporate Code of Conduct
The issuance was approved at the extraordinary shareholders meeting held on 18 July 2025, and the specific number of rights to be issued, the allotment date and other matters were determined by a resolution of the Board of Directors on 18 June 2026. Whether an independent third-party opinion was obtained is Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock options (share acquisition rights) (Series 10 share acquisition rights) |
| Number of shares to be issued or disposed of | 1,800,000 shares of the Company's common stock (maximum) |
| Issue price and disposal price | No cash payment is required in exchange for the share acquisition rights. |
| Intended allottee | Category 4 of the Company’s directors / Number of units 3,040 rights, Category 24 employees of the Company / Number of units 8,000 rights, Category 2 directors of subsidiaries of the Company / Number of units 650 rights, Category 103 employees of the Company's subsidiaries / Number of units 6,110 rights |
| Intended allottee's holding policy | The share acquisition rights may not be transferred, except with the special approval of the Company's Board of Directors. |
| Basis for determining the amount to be paid | The exercise price will be based on the average closing price of the Company's common stock on the Tokyo Stock Exchange for each trading day in the month preceding the month in which the allotment date falls, multiplied by 1.1 and rounded up to the nearest yen. If this amount is below the closing price on the allotment date, or the closing price on the immediately preceding trading day if no trades are made on the allotment date, the applicable closing price will be used. The discount or premium rate has not been specified. |
| Exercise price | Average closing price for each day of the month preceding the month in which the allotment date falls × 1.1 (rounded up to the nearest yen). However, the exercise price will not be lower than the closing price on the allotment date or the immediately preceding trading day. |
| Exercise period | Start Date 10 July 2028 / End date 10 July 2036 |
| Number of Stock Acquisition Rights | Total number issued 18,000 rights / Unexercised balance Not disclosed |
| Conditions for lifting transfer restrictions | The share acquisition rights may not be transferred, except with the special approval of the Company's Board of Directors. |
| Reason for acquisition without consideration | If a holder of the share acquisition rights ceases to satisfy the exercise conditions, If approval of a corporate reorganization transaction is approved at a shareholders meeting |
| Categories and Number of Persons Covered | 4 directors of the Company: 3,040 rights, 24 employees of the Company: 8,000 rights, 2 directors of the Company's subsidiaries: 650 rights, 103 employees of the Company's subsidiaries: 6,110 rights |
| Procedures under the Corporate Code of Conduct | The issuance was approved at the extraordinary shareholders meeting held on 18 July 2025, and the specific number of rights to be issued, the allotment date and other matters were determined by a resolution of the Board of Directors on 18 June 2026. Whether an independent third-party opinion was obtained is Not disclosed. |
Items this document does not state (15)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateDilution RateTotal number of issued sharesTransfer restriction periodTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The share acquisition rights will be issued as one form of incentive for directors, executive officers and employees of the Company and its subsidiaries.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.